nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Editorial Board/Aims and Scope
|
|
|
2015 |
33 |
28 |
p. IFC- 1 p. |
artikel |
2 |
Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014
|
Chang, Caiyun |
|
2015 |
33 |
28 |
p. 3223-3227 5 p. |
artikel |
3 |
Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity
|
Barman, Subrata |
|
2015 |
33 |
28 |
p. 3186-3192 7 p. |
artikel |
4 |
Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents
|
Wolff, Greg |
|
2015 |
33 |
28 |
p. 3228-3233 6 p. |
artikel |
5 |
Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus
|
Gari, Getachew |
|
2015 |
33 |
28 |
p. 3256-3261 6 p. |
artikel |
6 |
Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis
|
Estripeaut, Dora |
|
2015 |
33 |
28 |
p. 3200-3207 8 p. |
artikel |
7 |
Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis
|
Rozenbaum, Mark H. |
|
2015 |
33 |
28 |
p. 3193-3199 7 p. |
artikel |
8 |
Induction of CD8+ T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine
|
Pearson, Frances E. |
|
2015 |
33 |
28 |
p. 3248-3255 8 p. |
artikel |
9 |
Involvement of two microRNAs in the early immune response to DNA vaccination against a fish rhabdovirus
|
Bela-ong, Dennis Berbulla |
|
2015 |
33 |
28 |
p. 3215-3222 8 p. |
artikel |
10 |
Long term population impact of seven-valent pneumococcal conjugate vaccine with a “3+0″ schedule—How do “2+1″ and “3+1″ schedules compare?
|
Lowbridge, Christopher |
|
2015 |
33 |
28 |
p. 3234-3241 8 p. |
artikel |
11 |
Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine
|
Zhang, Tingting |
|
2015 |
33 |
28 |
p. 3208-3214 7 p. |
artikel |
12 |
MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7
|
Saleh, Tayebeh |
|
2015 |
33 |
28 |
p. 3164-3170 7 p. |
artikel |
13 |
One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery
|
Haidari, Leila A. |
|
2015 |
33 |
28 |
p. 3242-3247 6 p. |
artikel |
14 |
Pneumococcal vaccination in people living with HIV
|
Thornhill, John |
|
2015 |
33 |
28 |
p. 3159-3160 2 p. |
artikel |
15 |
Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination—Heplisav™ compared with Engerix-B® vaccine in adults
|
De Ridder, Marc |
|
2015 |
33 |
28 |
p. 3161- 1 p. |
artikel |
16 |
The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation
|
Vandermeulen, Gaëlle |
|
2015 |
33 |
28 |
p. 3179-3185 7 p. |
artikel |
17 |
Unusual positive effects from vaccines need to be reported – They represent a resource that could lead to new treatment strategies
|
Clarke, Margo S. |
|
2015 |
33 |
28 |
p. 3162-3163 2 p. |
artikel |
18 |
Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000–2013
|
Hibbs, Beth F. |
|
2015 |
33 |
28 |
p. 3171-3178 8 p. |
artikel |